Wei-Feng Zhang (Weifeng Zhang, Wenlong Jiang)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Acute Kidney Injury

Top Venues

Oxidative medicine and cellular longevity

Cardiology journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ruosen Yuan, Wei-Feng Zhang, Peng Nie, Keke Lan, Xiaoxiao Yang, Anwen Yin, Qingqing Xiao, Yejiao Shen, Ke Xu, Ben He, Xin Pan, Ling-Hong Shen, Ben He
Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis. Oxidative medicine and cellular longevity 2022 (2022)
Lian Chen, Xiaolei Wang, Qianyun Wang, Ding Ding, Wei-Feng Zhang, Zhengwen Ruan, Weifeng Zhang
Predictive value of two different definitions of contrast-associated acute kidney injury for long-term major adverse kidney events in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiology journal (2022)
Xiao-Lei Wang, Tuo Zhang, Liu-Hua Hu, Shi-Qun Sun, Wei-Feng Zhang, Zhe Sun, Ling-Hong Shen, Ben He
Comparison of Effects of Different Statins on Contrast-Induced Acute Kidney Injury in Rats: Histopathological and Biochemical Findings. Oxidative medicine and cellular longevity 2017 (2017)